Literature DB >> 8814236

The functional half-life of H-2Kd-restricted T cell epitopes on living cells.

G Eberl1, C Widmann, G Corradin.   

Abstract

The functional half-life (t1/2) of different complexes formed by major histocompatibility complex (MHC) class I molecules and antigen on the surface of target cells was measured using specific cytotoxic T lymphocyte (CTL) clones in cytolysis, and interferon-gamma-production and Ca(2+)-mobilization assays. Functional t1/2 values of 5-10 h were obtained, which are in accordance with some previous estimations obtained from biochemical and immunochemical measurements. Moreover, these values were independent of the type of target cell, fixation of the target cells, or proteases able to degrade the peptides, suggesting that the unfolding of the peptide/MHC complexes at the cell surface alone determines the functional t1/2 of the CTL epitopes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8814236     DOI: 10.1002/eji.1830260904

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A.

Authors:  S B Deitz; D A Dodd; S Cooper; P Parham; K Kirkegaard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes.

Authors:  Niels A W Lemmermann; Kerstin Gergely; Verena Böhm; Petra Deegen; Torsten Däubner; Matthias J Reddehase
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

3.  Nonstructural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus.

Authors:  Kouacou V Konan; Thomas H Giddings; Masanori Ikeda; Kui Li; Stanley M Lemon; Karla Kirkegaard
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 4.  Killing of dendritic cells: a life cut short or a purposeful death?

Authors:  F Ronchese; I F Hermans
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

Review 5.  Current Concepts of Antigen Cross-Presentation.

Authors:  Maria Embgenbroich; Sven Burgdorf
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

6.  Cross-presentation: how to get there - or how to get the ER.

Authors:  Christoph Kreer; Judith Rauen; Matthias Zehner; Sven Burgdorf
Journal:  Front Immunol       Date:  2012-01-03       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.